NYSEAMERICAN:NSPR - InspireMD Stock Price, Forecast & News

InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."

Shares of InspireMD reverse split on the morning of Monday, April 1st 2019. The 1-50 reverse split was announced on Tuesday, March 26th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 29th 2019. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 2 shares after the split.

InspireMD Inc (NYSEAMERICAN:NSPR) issued its quarterly earnings data on Monday, August, 6th. The medical equipment provider reported ($7.50) earnings per share (EPS) for the quarter. The medical equipment provider earned $1 million during the quarter. View InspireMD's Earnings History.

InspireMD is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for InspireMD.

1 Wall Street analysts have issued twelve-month price targets for InspireMD's stock. Their forecasts range from $5.00 to $5.00. On average, they anticipate InspireMD's share price to reach $5.00 in the next year. This suggests a possible upside of 461.8% from the stock's current price. View Analyst Price Targets for InspireMD.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for InspireMD.

Media stories about NSPR stock have trended somewhat negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. InspireMD earned a news sentiment score of -1.1 on InfoTrie's scale. They also gave news coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for InspireMD.

Some companies that are related to InspireMD include LiDCO Group (LID), Deltex Medical Group (DEMG), Zecotek Photonics (ZMS), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS).

Based on aggregate information from My MarketBeat watchlists, some companies that other InspireMD investors own include Palatin Technologies (PTN), TransEnterix (TRXC), Catalyst Pharmaceuticals (CPRX), Curis (CRIS), Novavax (NVAX), AVEO Pharmaceuticals (AVEO), Inovio Pharmaceuticals (INO), Rexahn Pharmaceuticals (REXN), Verastem (VSTM) and NovaBay Pharmaceuticals (NBY).

InspireMD's stock is owned by many different of retail and institutional investors. Top institutional investors include Sabby Management LLC (8.63%) and Wedbush Securities Inc. (2.14%). Company insiders that own InspireMD stock include Paul Stuka and Thomas J Kester. View Institutional Ownership Trends for InspireMD.

NSPR stock was purchased by a variety of institutional investors in the last quarter, including Sabby Management LLC and Wedbush Securities Inc.. View Insider Buying and Selling for InspireMD.

Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NSPR stock can currently be purchased for approximately $0.89.

InspireMD has a market capitalization of $3.23 million. InspireMD employs 43 workers across the globe.View Additional Information About InspireMD.

The official website for InspireMD is http://www.inspiremd.com/.

InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553.